BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16575271)

  • 21. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure.
    Lang CC; Karlin P; Haythe J; Tsao L; Mancini DM
    Am J Cardiol; 2007 Feb; 99(3):404-5. PubMed ID: 17261407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights.
    Guazzi M; Dickstein K; Vicenzi M; Arena R
    Circ Heart Fail; 2009 Nov; 2(6):549-55. PubMed ID: 19919979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Greater prognostic value of peak VO2 after exercise training program completion in heart failure patients.
    Tabet JY; Meurin P; Benzidi Y; Beauvais F; Ben Driss A; Weber H; Renaud N; Dumaine R; Grosdemouge A; Cohen Solal A
    Int J Cardiol; 2013 Oct; 168(4):4139-44. PubMed ID: 23911267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of functional and health status measures in heart failure.
    Myers J; Zaheer N; Quaglietti S; Madhavan R; Froelicher V; Heidenreich P
    J Card Fail; 2006 Aug; 12(6):439-45. PubMed ID: 16911910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of peak oxygen consumption during exercise for the prognostic stratification of patients with severe systolic dysfunction of the left ventricle].
    Passantino A; Scrutinio D; Lagioia R; Forleo C; Ricci A; Rizzon P
    Cardiologia; 1997 Sep; 42(9):947-52. PubMed ID: 9410568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of increase of cardiac index during exercise in the chronic phase of various cardiovascular diseases: evaluation by exercise tolerance and brain natriuretic peptide].
    Omiya K; Tanabe K; Samejima H; Suzuki N; Yokoyama Y; Yamamoto A; Nakayama M; Osada N; Yamamoto M; Itoh H; Murayama M
    J Cardiol; 1997 Mar; 29(3):149-56. PubMed ID: 9095445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of heart rate recovery in patients with heart failure.
    Arena R; Guazzi M; Myers J; Peberdy MA
    Am Heart J; 2006 Apr; 151(4):851.e7-13. PubMed ID: 16569547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of cardiopulmonary exercise testing and brain natriuretic peptide plasma levels in predicting the prognosis of patients with chronic heart failure.
    Krüger S; Graf J; Merx MW; Stickel T; Kunz D; Koch KC; Hanrath P; Janssens U
    Eur J Intern Med; 2006 Mar; 17(2):96-101. PubMed ID: 16490685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reproducibility of measurements of blood gas exchange during exercise in mild cardiac failure: need for a preliminary test?].
    Valy Y; Coisne D; Ingrand P; Christiaens L; Boyer P; Allal J; Barraine R
    Arch Mal Coeur Vaiss; 1997 Apr; 90(4):477-82. PubMed ID: 9238465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope.
    Davies LC; Wensel R; Georgiadou P; Cicoira M; Coats AJ; Piepoli MF; Francis DP
    Eur Heart J; 2006 Mar; 27(6):684-90. PubMed ID: 16338939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence.
    Corrà U; Pistono M; Mezzani A; Braghiroli A; Giordano A; Lanfranchi P; Bosimini E; Gnemmi M; Giannuzzi P
    Circulation; 2006 Jan; 113(1):44-50. PubMed ID: 16380551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of exercise capacity improvement after exercise training program: a strong prognostic factor in patients with chronic heart failure.
    Tabet JY; Meurin P; Beauvais F; Weber H; Renaud N; Thabut G; Cohen-Solal A; Logeart D; Ben Driss A
    Circ Heart Fail; 2008 Nov; 1(4):220-6. PubMed ID: 19808295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of cardiac resynchronisation therapy on adaptation of circulatory and respiratory systems to exercise assessed by cardiopulmonary exercise test in patients with chronic heart failure.
    Chwyczko T; Sterliński M; Maciag A; Firek B; Labecka A; Jankowska A; Kośmicki M; Kowalik I; Malczewska B; Szwed H
    Kardiol Pol; 2008 Apr; 66(4):406-12; discussion 413-4. PubMed ID: 18473269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise oscillatory ventilation may predict sudden cardiac death in heart failure patients.
    Guazzi M; Raimondo R; Vicenzi M; Arena R; Proserpio C; Sarzi Braga S; Pedretti R
    J Am Coll Cardiol; 2007 Jul; 50(4):299-308. PubMed ID: 17659196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise ventilation inefficiency and cardiovascular mortality in heart failure: the critical independent prognostic value of the arterial CO2 partial pressure.
    Guazzi M; Reina G; Tumminello G; Guazzi MD
    Eur Heart J; 2005 Mar; 26(5):472-80. PubMed ID: 15618042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diastolic function and BNP changes during exercise predict oxygen consumption in chronic heart failure patients.
    Ciampi Q; Borzillo G; Barbato E; Petruzziello B; Betocchi S; Villari B
    Scand Cardiovasc J; 2009 Feb; 43(1):17-23. PubMed ID: 18609042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course of effects of cardiac resynchronization therapy in chronic heart failure: benefits in patients with preserved exercise capacity.
    Piepoli MF; Villani GQ; Corrà U; Aschieri D; Rusticali G
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):701-8. PubMed ID: 18507542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic ability of VE/VCO2 slope calculations using different exercise test time intervals in subjects with heart failure.
    Arena R; Humphrey R; Peberdy MA
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):463-8. PubMed ID: 14671470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.